How the Neurological Disorder Diagnostics Market Will Grow: Key Trends, Market Size, and Opportunities Beyond 2025
2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
What Major Innovations Are Driving the Accelerated Growth of the Neurological Disorder Diagnostics Market?
The growing incidence of Alzheimer’s disease is expected to fuel the growth of the neurological disorder diagnostics market. Alzheimer’s is a progressive neurodegenerative disorder leading to a gradual decline in cognitive abilities. The disease is influenced by genetic factors, the accumulation of amyloid plaques and tau tangles, and lifestyle choices. Neurological diagnostics play a vital role in detecting Alzheimer’s early, using techniques like imaging, biomarker analysis, and cognitive testing. For instance, the Australian Institute of Health and Welfare reported that about 411,100 individuals in Australia were living with dementia in 2023, including 257,500 women and 153,700 men. As a result, the rising prevalence of Alzheimer’s disease is driving the growth of the neurological disorder diagnostics market.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19611&type=smp
How Will the Growth Rate of theNeurological Disorder Diagnostics Market Impact Industry Trends by 2034?
The neurological disorder diagnostics market size will grow from $11.75 billion in 2024 to $12.61 billion in 2025 at a compound annual growth rate (CAGR) of 7.3%. The growth in the historic period is attributed to an increase in the prevalence of neurological disorders, an aging population, emphasis on early diagnosis and disease management, awareness of neurological disorders, and focus on early diagnosis.
The neurological disorder diagnostics market size is projected to reach $16.6 billion by 2029, growing at a CAGR of 7.1%. The growth is attributed to rising awareness, healthcare expenditure, improved access to services, expansion of diagnostic centers, and adoption of personalized medicine. Trends include advancements in neuroimaging, wearable devices, biomarker discovery, AI integration, and point-of-care diagnostic devices.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19611
What Are the Most Significant Market Trends Transforming theNeurological Disorder Diagnostics Market?
Companies in the neurological disorder diagnostics market are developing advanced solutions like neurological disease quantification software to assist the billion individuals affected by neurological diseases globally. This software is designed to measure and analyze brain function in neurological conditions. For example, Quibim, a biotechnology company based in Spain, launched the QP-Brain in January 2024, an AI-based early-stage neurological disease quantification software. It uses AI for automated segmentation and detailed analysis to offer precise insights into brain structure changes for both clinical and research purposes.
What Are the Top Market Players Propelling the Growth of theNeurological Disorder Diagnostics Industry?
Major companies operating in the neurological disorder diagnostics market are Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Novartis AG, Medtronic plc, Amgen Inc., Siemens Healthineers AG, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Otsuka Pharmaceutical Co. Ltd., Boston Scientific Corporation, Neurocrine Biosciences Inc., Neusoft Medical Systems Co. Ltd., Nihon Kohden Corporation, Natus Medical Incorporated, Esaote S.p.A, Canon Medical Systems Corporation, NeuroPace Inc., Lifelines Neuro Company LLC, York Instruments Ltd., Advanced Brain Monitoring Inc., Neurometrix Inc., Croton Healthcare Private Limited, NeuroLogica Corporation
Order Your Report Now For A Swift Delivery:
Which Primary Segments of the Neurological Disorder Diagnostics Market Are Driving Growth and Industry Transformations?
The neurological disorder diagnosticsmarket covered in this report is segmented –
1) By Component: Instruments, Reagents, Kits, Software, Services
2) By Technology: Immunoassay, Polymerase Chain Reaction (PCR) Techniques
3) By Disease Type: Alzheimer’s Disease, Dementia, Parkinson’s Disease, Epilepsy, Traumatic Brain Injury, Other Disease Types
4) By End User: Hospitals And Clinics, Diagnostic Centers, Academic And Research Institutes
Subsegments:
1) By Instruments: Electroencephalography (EEG) Machines, Magnetic Resonance Imaging (MRI) Machines, Computed Tomography (CT) Scanners, Positron Emission Tomography (PET) Scanners, Lumbar Puncture Equipment, Ultrasound Devices, Neurostimulation Devices, Transcranial Magnetic Stimulation (TMS) Devices,
2) By Reagents: Biochemical Reagents, Antibodies, DNA Probes, RNA Probes, Enzyme-linked Immunosorbent Assay (ELISA) Reagents, Polymerase Chain Reaction (PCR) Reagents, Sample Collection Reagents
3) By Kits: Diagnostic Test Kits, Genetic Testing Kits, Biomarker Detection Kits, Immunoassay Kits, Point-of-Care Testing Kits, Screening Kits for Neurological Disorders
4) By Software: Diagnostic Software for Imaging Analysis, Data Management Software, Clinical Decision Support Software, Patient Management Software, Laboratory Information Management Systems (LIMS), Neuroinformatics Software, Telemedicine Software
5) By Services: Diagnostic Testing Services, Consultation Services, Training and Support Services, Maintenance and Repair Services for Equipment, Telehealth Services, Data Analysis Services, Research and Development Services
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=19611&type=smp
Which Regions Are Key Players in the Growth of the #What Major Innovations Are Driving the Accelerated Growth of the Neurological Disorder Diagnostics Market?# Market?
North America was the largest region in the neurological disorder diagnostics market in 2024. The regions covered in the neurological disorder diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Reports Similar to the Global Neurological Disorder Diagnostics Market 2025, By The Business Research Company:
Diabetic Neuropathy Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/diabetic-neuropathy-global-market-report
Intraoperative Neuromonitoring Global Market Report 2024
Interventional Neurology Devices And Equipment Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
